Colombo, March 26 (IANS) Sri Lankan President Gotabaya Rajapaksa has appealed to international donor agencies to provide debt relief to vulnerable and developing nations who have been hit by the COVID-19 virus, his office said in a statement.
The statement said Rajapaksa has urged director general of the World Health Organization to forward this request to multi-lateral and bilateral lending agencies as economic conditions of these countries were affected by the virus outbreak, Xinhua reported.
"President points out this relief would be helpful to manage COVID-19 Social Distancing, Public Health and Social Security Systems in these countries," the statement said on Wednesday.
Sri Lanka's economy has been affected in recent days since the country remains under a curfew to prevent the further spread of COVID-19 which has so far infected 101 people while over 200 remain under observation in hospitals.
Over 11,500 are also under quarantine in homes and centres.
The government has banned people from leaving their homes especially in capital Colombo which has seen the highest number of cases in recent weeks, according to statistics from the Health Ministry.
The island's tourism sector, which was one of the largest foreign exchange earners has also received a blow since the international airport banned passenger arrivals since last week, until further notice.
Are you an Ayurveda doctor? Download our App from Google PlayStore now!
Download NirogStreet App for Ayurveda Doctors. Discuss cases with other doctors, share insights and experiences, read research papers and case studies. Get Free Consultation 9625991603 | 9625991607 | 8595299366
New York, Jan 28 (IANS) Women, take note. Contracting Covid-19 while expecting a baby can have deadly consequences, a new study suggests.The findings suggested that the Covid-...
Panaji- Union Minister of State for Defence, Shripad Naik, is recovering well and may be discharged from hospital in 10 days, a top health official said on Thursday. &...
New York, Jan 28 (IANS) Drugmakers Pfizer and BioNTech have said that their Covid-19 vaccine has been found in laboratory studies to work against new variants first identified...